Moneycontrol PRO
Loans
HomeNewsBusinessDr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang

Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang

Net Sales are expected to increase by 22.3 percent Y-o-Y (down 3.1 percent Q-o-Q) to Rs 6,099.1 crore, according to Nirmal Bang.

July 12, 2023 / 12:24 IST
Pharmacy

Pharmacy

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Nirmal Bang has come out with its first quarter (April - June’ 24) earnings estimates for the Pharmaceutical sector. The brokerage house expects Dr Reddys Laboratories to report net profit at Rs 912.4 crore up 73.7% year-on-year (down 4.9% quarter-on-quarter).

Net Sales are expected to increase by 22.3 percent Y-o-Y (down 3.1 percent Q-o-Q) to Rs 6,099.1 crore, according to Nirmal Bang.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 102.2 percent Y-o-Y (down 8.2 percent Q-o-Q) to Rs 1,402.8 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Nirmal Bang_Pharmaceutical

Broker Research
first published: Jul 12, 2023 12:24 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347